Merck KGaA (MKKGY)
32.44
-0.46
(-1.40%)
USD |
OTCM |
Apr 24, 16:00
Merck Free Cash Flow (Quarterly): 500.85M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 500.85M |
| September 30, 2023 | 863.68M |
| June 30, 2023 | 324.99M |
| March 31, 2023 | 216.96M |
| December 31, 2022 | 602.39M |
| September 30, 2022 | 1.031B |
| June 30, 2022 | 569.56M |
| March 31, 2022 | 383.76M |
| December 31, 2021 | 931.66M |
| September 30, 2021 | 1.082B |
| June 30, 2021 | 737.71M |
| March 31, 2021 | 1.029B |
| December 31, 2020 | 652.76M |
| September 30, 2020 | 1.079B |
| June 30, 2020 | 280.49M |
| March 31, 2020 | 173.26M |
| December 31, 2019 | 410.86M |
| September 30, 2019 | 780.65M |
| June 30, 2019 | 550.39M |
| March 31, 2019 | 312.38M |
| December 31, 2018 | 492.63M |
| September 30, 2018 | 573.26M |
| June 30, 2018 | 193.69M |
| March 31, 2018 | 160.93M |
| December 31, 2017 | 207.15M |
| Date | Value |
|---|---|
| September 30, 2017 | 661.61M |
| June 30, 2017 | 308.81M |
| March 31, 2017 | 390.96M |
| December 31, 2016 | 516.76M |
| September 30, 2016 | 955.32M |
| June 30, 2016 | 177.64M |
| March 31, 2016 | 198.57M |
| December 31, 2015 | 506.54M |
| September 30, 2015 | 698.32M |
| June 30, 2015 | 236.26M |
| March 31, 2015 | 225.66M |
| December 31, 2014 | 1.151B |
| September 30, 2014 | 715.96M |
| June 30, 2014 | 430.64M |
| March 31, 2014 | 470.46M |
| December 31, 2013 | 303.18M |
| September 30, 2013 | 985.74M |
| June 30, 2013 | 387.51M |
| March 31, 2013 | 593.14M |
| December 31, 2012 | 313.52M |
| September 30, 2012 | 973.19M |
| June 30, 2012 | 769.05M |
| March 31, 2012 | 514.09M |
| December 31, 2011 | -170.76M |
| September 30, 2011 | 757.44M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
173.26M
Minimum
Mar 2020
1.082B
Maximum
Sep 2021
642.18M
Average
602.39M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Affimed NV | -27.55M |
| InflaRx NV | -11.65M |
| MorphoSys AG | -- |
| BioNTech SE | 690.54M |
| Immatics NV | 76.06M |